Investors and Partners

Investors & partners

Our Partners

Vaccitech is a private limited company with multiple investors.

Vaccitech continues to develop its clinical programs to treat and prevent infectious diseases and cancer through key milestones.

Vaccitech seeks and is open to forming industry collaborations and partnerships on its programs and to license its platform technology to target new indications.

We have also entered into non-exclusive licensure of our T-cell induction platform in oncology, and are committed to advancing the use of our platform for oncology in combination with checkpoint inhibitors.

Hover over the logos below for more information.
Oxford Sciences Innovation find the most innovative ideas coming out of Oxford, and invest in them to build world-class companies.

Website

The University of Oxford is a collegiate research university located in Oxford, England, United Kingdom. While having no known date of foundation, there is evidence of teaching as far back as 1096, making it the oldest university in the English-speaking world and the world’s second-oldest surviving university.

Website

Emergent BioSolutions provides specialty products for civilian and military populations that address intentional and naturally emerging public health threats.

Website

Batavia Biosciences accelerates the transition of biopharmaceutical candidates from discovery to the clinic with improved success rates and lower costs.

Website

Oxford Genetics improves the design and development of biological therapeutics via DNA design and the optimisation of virus and protein expression systems.

Website

Oxford University Innovation is a wholly-owned subsidiary of the University of Oxford. OUI manages the University’s technology transfer and consulting activities and provide an innovation management service to clients around the world.

Website

A world renowned centre of clinical excellence and one of the largest NHS teaching trusts in the UK – this enables them to work more effectively in partnership with their patients and their local community to provide high quality healthcare.

Website

Formed in 2005, Sequoia Capital China has an impressive and diverse portfolio that delivers high returns on investment using differentiated technologies and innovative business models. They have offices in Hong Kong, Beijing, Shanghai, Guangzhou, Hangzhou, Suzhou and Shenzhen.

Website

Founded in 2000, GeneMatrix is a KOSDAQ listed company that uses clinical data to improve human health and welfare. The company has developed theranostic solutions for health problems to become the Korean market leader for HBV, HCV, HIV, and Human Papilloma Virus genotyping.

Website

Established in 2002, Neptune is a UK-based fund management company established offering a range of ISA-friendly equity funds to private investors, advisers and institutional clients. The hallmark of each fund is pure active investment management executed with conviction. 

Website

Korea Investment Partners is a leading global venture capital & private equity firm with over 30 years of experience in providing venture capital to bold and innovative entrepreneurs who want to change the world. They have offices in Seoul,Shanghai, Beijing, and Sunnyvale.

Website

Launched as Google Ventures in 2009, GV is the venture capital arm of Alphabet, Inc. GV invested in more than 300 companies in the fields of life science, healthcare, artificial intelligence, robotics, transportation, cyber security, and agriculture. GV companies aim to improve lives and change industries. 

Website